Clinuvel (CUV) is held by 5 ASX ETFs. Over the last year it fell 35.6%: on $10,000, −$3556. We explain 8 big moves in that time.
About CUV
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$406.4m
- Held by5 ETFs
- Big moves8 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +2.7%peak +3.6%1 Sep 2026· Operational
Clinuvel's announcement that it is considering a Nasdaq listing and potential ASX delisting spooked ASX investors, triggering a sell-off on elevated volume several days after the news dropped.
- −12.7%peak −18.5%27 Aug 2026· Earnings Miss
Clinuvel's FY26 full-year results disappointed the market, triggering a sharp sell-off despite a decade of profitability headline, as investors reacted negatively to the actual numbers or forward outlook in the annual report and preliminary final report released minutes before the price move.
- +5.8%peak +6.3%18 Aug 2026· Sector Flow
CUV rose sharply as the broader ASX healthcare sector surged strongly on the same day, lifting sector peers including CUV.
- −7.4%2 Apr 2026· Sector Flow
Likely sector-wide decline in Australian shares on April 1, 2026, with no company-specific negative news identified.
- −9.3%27 Feb 2026· Earnings Miss
Clinuvel Pharmaceuticals H1 FY2026 profit declined 26% due to margin compression, disappointing investors despite record revenue.
- +11.9%16 Feb 2026· Unknown
No specific catalyst identified; the article merely lists CLINUVEL as an ASX biotech watchlist firm.
- −6.4%11 Feb 2026· Unknown
Abnormal price drop not explained by available news; likely driven by unannounced factors or sector flow.
- +5.0%19 Dec 2025· Unknown
No specific news was found to explain the 5% price movement; the cause remains unidentified.
Held by 5 ETFs
Of every $10,000 in each fund, how much is in CUV today.